As we know, GSH/GSSH ratio is a key factor to determine oxidative stress level in cell or tissue. But, can I induce oxidative stress by GSSG in cell? If I could, how does GSSG induce oxidative stress?
In mammals, the intracellular synthesis of glutathione and its utilization is described by the g-glutamyl cycle, a concept that was put forth almost four decades ago 1. Reduced glutathione represents the centerpiece of the g-glutamyl cycle, involved in several fundamental biological functions, including free radical scavenging, detoxification of xenobiotics and carcinogens, redox reactions, biosynthesis of DNA, proteins and leukotrienes, as well as neurotransmission. While GSH may form numerous adducts in the human body2, the most abundant GSH derivative is represented by GSSG. Oxidation of intracellular GSH by oxidants such as hydrogen peroxide and organic peroxides generally leads to the formation of GSSG. GSH can be further oxidized to the sulfenic, sulfinic, and sulfonic acid derivatives via successive two-electron oxidations of the thiol group.
GSSG is mostly viewed as a byproduct of GSH generated following reaction of GSH with an oxidizing species. As a result, GSSG/GSH ratio in the tissue emerged as a frequently used biochemical measure of oxidative stress 3. Advances in the concept of redox signaling, and redefining of oxidative stress in that light 4, has led to rethinking of the significance of GSSG in the cell 5. It is now widely acknowledged that changes in the cellular reduced/oxidized glutathione ratio trigger signal transduction mechanisms influencing cell survival. GSSG is capable of causing protein S-glutathionylation or reversible formation of protein mixed disulfides (protein-SSG). Post-translational reversible S-glutathionylation is known to regulate signal transduction as well as activities of several redox sensitive thiol-proteins 6.
Studies with exogenous non-permeable GSSG have demonstrated that extracellular GSSG may trigger apoptosis by a redox-mediated p38 mitogen-activated protein kinase pathway 7. While this addresses the significance of extracellular GSSG, the specific properties of intracellular GSSG remain under veil. GSH is oxidized to GSSG within the cell and pumped to the extracellular compartment 8, 9. Intracellular compartment being the primary site of GSSG generation, the significance of this disulfide within the cell becomes an important issue to address. Studies examining the significance of intracellular GSSG are complicated by the lack of a specific approach that would only elevate intracellular GSSG levels. For example, exposure of cells to pathogen related chemicals or to direct oxidant insult does elevate cellular GSSG but activates numerous other aspects of cell signaling 10. While the study of GSSG driven reactions in a cell-free system is relatively straightforward in approach, the in vivo significance of such findings remains questionable 11. This work presents first evidence from the use of a microinjection approach to study the significance of GSSG within the cell. Previously, we have utilized this approach to differentially study the cytosolic and nuclear compartments of HT4 cells as well as of primary cortical neurons 12. The approach is powerful in instantly and selectively introducing agents into specific compartments of the cell. Results of this study provide the first evidence demonstrating that the specific elevation of GSSG within the cell may cause cell death. Our observation demonstrating loss of mitochondrial membrane potential without affecting cell membrane integrity argues in favor of an apoptotic fate. Disorders of the central nervous system are frequently associated with concomitant glutathione depletion and oxidation 13, 14. Our observation that cells with compromised GSH levels are substantially more sensitive to GSSG-induced death leads to the notion that GSSG may play a role in cell death under conditions of disease and aging. We note that in GSH-sufficient cells (experimental) 0.5 mM GSSG is lethal. In GSH-deficient cells, a condition that mimics oxidative stress situation, the threshold of lethality sharply goes down by 20 fold to 0.025 mM GSSG. Our estimates show that in HT4 neural cells, total GSH content is in the range of 13 mM (not shown). This is consistent with the literature reporting that under basal conditions, cellular GSH levels is in the tune of 10 mM15, 16. In response to oxidant insult, GSSG levels sharply go up and may represent up to 50% of the total GSH in the cell 17, 18. Oxidative stress depletes cellular reducing equivalents such NADPH 19 compromising GSSG reductase function.
Glutamate toxicity is a major contributor to pathological cell death within the nervous system and is known to be mediated by reactive oxygen species and GSH loss 20, 21. Glutamate-induced death of neural cells is known to be associated with GSH loss and oxidation 22, 23. Our previous studies have identified 12-lipoxygenase as a key mediator of glutamate-induced neural cell death 24. We and others have reported that 12-lipoxygenase deficient mice are protected against stroke dependent injury to the brain 24, 25. GSH depletion causes neural degeneration by activating the 12-Lox pathway26, 27. Observations in this study suggest a direct influence of GSSG on 12-lipoxygenase activation. Arachidonic acid is converted into several more polar products in addition to 12-l-hydroperoxyeicosa-5,8,10,14-tetraenoic acid (12-HPETE) and 12-l-hydroxyeicosa-5,8,10,14-tetraenoic acid (12-HETE) by 12-lipoxygenase. Previously it has been demonstrated that the presence of 0.5-1.5 mM GSH in the reaction mixture prevents the formation of the more polar products and produces 12-HETE as the only metabolite from arachidonic acid by the 12-lipoxygenase pathway. It was therefore concluded that 12-HPETE peroxidase in the 12-lipoxygenase pathway is a GSH-dependent peroxidase and the more polar products might be formed from the non-enzymatic breakdown of the primary 12-lipoxygenase product of 12-HPETE, owing to insufficient capability of the subsequent peroxidase system to completely reduce 12-HPETE to 12-HETE 28. In a cell system, disulfides are known to be able to act as biological oxidants that oxidize the zinc-thiolate clusters in metallothionein with concomitant zinc release 29. Intracellular zinc release is known to cause 12-lipoxygenase activation and neurotoxicity 30. Studies with BSO-treated GSH-deficient cells highlighted the significance of microinjected free arachidonic acid in neurotoxicity. These observations are consistent with the literature reporting a central role of the free arachidonic acid mobilizing enzyme phospholipase A2 in neurotoxicity 31.
S-Glutathionylated proteins (PSSG) can result from thiol/disulfide exchange between protein thiols (PSH) and GSSG 32. Protein S-glutathionylation, the reversible binding of glutathione to low-pKa cysteinyl residues in PSH, is involved in the redox regulation of protein function. Several enzymes are known to undergo this post translational modification. Importantly, whether glutathionylation inhibits or augments protein function may vary depending on the individual case. For example, glutathionylation inhibits phosphofructokinase 33, NFkB 34, glyceraldehydes-3-phosphate dehydrogenase 35, protein kinase C-α 36, creatine kinase 4, as well as actin 37. In contrast, glutathionylation-dependent gain of protein function has been reported for microsomal glutathione S-transferase 38, HIV-1 protease-Cys67 39, and matrix metalloproteinases 40. Furthermore, specific electron transport proteins of the mitochondria are sensitive to S-glutathionylation 19, 41. Consistently, we noted that GSSG induced cell death was associated with loss of mitochondrial membrane potential. The presence of multiple cysteine residues in 12-lipoxygenase makes it susceptible to S-glutathionylation. Results of this study provide first evidence demonstrating that 12-lipoxygenase may be glutathionylated in glutamate challenged neural cells. The finding that both glutaredoxin-1 expression as well as delivery may protect cells against glutamate-induced neurotoxicity suggests that glutamate-induced glutathionylation is implicated in the cell death pathway. GSSG is a functionally active byproduct of GSH metabolism that, under appropriate conditions, may trigger cell death. S-glutathionylation seems to be a mechanism that favors 12-lipoxygenase but not the classical caspase-3 dependent 42 death pathway.
The GSSG reductase inhibitor BCNU, clinically known as carmustine, is a proven chemotherapeutic agent 43. Cytotoxicity is a widely recognized side-effect of BCNU 44. Because BCNU treatment is associated with GSSG accumulation in cells 45, the significance of GSSG in BCNU-induced cytotoxicity is of interest. Observations of this study support that both GSSG as well as BCNU-induced cell death follow the same 12-lipoxygenase dependent path suggesting the possibility that BCNU may cause cell death via GSSG. Affirmation of this hypothesis would warrant examining the significance of pro-GSSG strategies for cancer therapy. Major forms of cancer therapy including radiation therapy as well as chemotherapy rely on oxygen-centered free radicals for their action. Thus, these interventions cause overt oxidative insult associated with elevated levels of cellular and tissue GSSG 46, 47. GSSG generated within the cell is pumped out of the cell perhaps to avert cytotoxicity caused by GSSG accumulation. Approaches to selectively block the GSSG efflux mechanisms in cancer cells might be useful for cancer therapy. Findings of this study support that BSO sensitizes cells to GSSG-induced death. Indeed, BSO has been founds to be an useful adjunct for both radiation 48 as well as chemotherapy 49. Also, inhibition of GSSG efflux by inhibition of MRP1 enhanced BCNU-induced cytoxicity suggesting that GSSG extrusion play a role in neural sensitivity to GSSG.
Three-fourth of all stroke in humans occur in distributions of the middle cerebral artery 50. Therefore, MCAO represents a common approach to study stroke in small as well as large animals 12. Using a MCAO approach we were able to obtain just over 16% infarction of the ipsilateral hemisphere as assessed by MRI. Stroke caused 8-fold increased in GSSG levels in the affected brain tissue. This is consistent with the known incidence of oxidative stress in the stroke affected brain 51. Our observation that the stereotaxic injection of GSSG to the brain may cause lesion by a 12-lipoxygenase sensitive mechanism leads to question the significance of GSSG in numerous brain pathologies commonly associated with elevated levels of GSSG in the brain 52, 53.
Taken together, this work presents first evidence demonstrating that intracellular GSSG may trigger cell death. GSSG cytotoxicity is substantially enhanced under conditions of compromised cellular GSH levels as observed during a wide variety of disease conditions as well as aging 53, 54. BSO-assisted glutathione lowering approaches are known to be effective to facilitate both chemo- as well as radiation- therapies. Furthermore, BCNU-dependent arrest of GSSG reductase activity leads to elevation of cellular GSSG and has chemotherapeutic functions. Findings of this study lead to question the significance of GSSG in such processes. From the standpoint of novel therapeutic approaches, strategies directed at improving or arresting cellular GSSG clearance may be effective in minimizing oxidative stress related tissue injury or potentiating the killing of tumor cells, respectively.
References
1. Orlowski M, Meister A. The gamma-glutamyl cycle: a possible transport system for amino acids. Proc Natl Acad Sci U S A 1970; 67: 1248-1255.
3. Schafer FQ, Buettner GR. Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. Free Radic Biol Med 2001; 30: 1191-1212.
4. Reddy S, Jones AD, Cross CE, Wong PS, Van Der Vliet A. Inactivation of creatine kinase by S-glutathionylation of the active-site cysteine residue. Biochem J 2000; 347 Pt 3: 821-827.
5. Circu ML, Aw TY. Glutathione and apoptosis. Free Radic Res 2008; 42: 689-706.
6. Mieyal JJ, Gallogly MM, Qanungo S, Sabens EA, Shelton MD. Molecular mechanisms and clinical implications of reversible protein s-glutathionylation. Antioxid Redox Signal 2008; 10: 1941-1988.
7. Filomeni G, Rotilio G, Ciriolo MR. Glutathione disulfide induces apoptosis in U937 cells by a redox-mediated p38 MAP kinase pathway. Faseb J 2003; 17: 64-66.
8. Sen CK, Rahkila P, Hanninen O. Glutathione metabolism in skeletal muscle derived cells of the L6 line. Acta Physiol Scand 1993; 148: 21-26.
9. Srivastava SK, Beutler E. The transport of oxidized glutathione from human erythrocytes. J Biol Chem 1969; 244: 9-16.
10. Kirsch JD, Yi AK, Spitz DR, Krieg AM. Accumulation of glutathione disulfide mediates NF-kappaB activation during immune stimulation with CpG DNA. Antisense Nucleic Acid Drug Dev 2002; 12: 327-340.
11. den Hartog GJ, Haenen GR, Vegt E, van der Vijgh WJ, Bast A. Efficacy of HOCl scavenging by sulfur-containing compounds: antioxidant activity of glutathione disulfide? Biol Chem 2002; 383: 709-713.
12. Khanna S, Roy S, Slivka A, Craft TK, Chaki S, Rink C, et al. Neuroprotective properties of the natural vitamin E alpha-tocotrienol. Stroke 2005; 36: 2258-2264.
13. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003; 384: 505-516.
14. Schulz JB, Lindenau J, Seyfried J, Dichgans J. Glutathione, oxidative stress and neurodegeneration. Eur J Biochem 2000; 267: 4904-4911.
15. Meister A, Anderson ME. Glutathione. Annu Rev Biochem 1983; 52: 711-760.
16. Shaw CA. Glutathione in the nervous system. Taylor & Francis: Washington, DC, 1998, xiv, 389pp.
17. Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R. The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem 2006; 97: 373-384.
18. Pias EK, Aw TY. Early redox imbalance mediates hydroperoxide-induced apoptosis in mitotic competent undifferentiated PC-12 cells. Cell Death Differ 2002; 9: 1007-1016.
19. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG. Selenium-dependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. Faseb J 1999; 13: 1467-1475.
20. Coyle JT, Puttfarcken P. Oxidative stress, glutamate, and neurodegenerative disorders. Science 1993; 262: 689-695.
21. Herrera F, Martin V, Garcia-Santos G, Rodriguez-Blanco J, Antolin I, Rodriguez C. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria. J Neurochem 2007; 100: 736-746.
22. Sen CK, Khanna S, Roy S, Packer L. Molecular basis of vitamin E action. Tocotrienol potently inhibits glutamate-induced pp60(c-Src) kinase activation and death of HT4 neuronal cells. J Biol Chem 2000; 275: 13049-13055.
23. Tirosh O, Sen CK, Roy S, Packer L. Cellular and mitochondrial changes in glutamate-induced HT4 neuronal cell death. Neuroscience 2000; 97: 531-541.
24. Khanna S, Roy S, Ryu H, Bahadduri P, Swaan PW, Ratan RR, et al. Molecular basis of vitamin E action: tocotrienol modulates 12-lipoxygenase, a key mediator of glutamate-induced neurodegeneration. J Biol Chem 2003; 278: 43508-43515.
25. van Leyen K, Kim HY, Lee SR, Jin G, Arai K, Lo EH. Baicalein and 12/15-lipoxygenase in the ischemic brain. Stroke 2006; 37: 3014-3018.
26. Canals S, Casarejos MJ, de Bernardo S, Rodriguez-Martin E, Mena MA. Nitric oxide triggers the toxicity due to glutathione depletion in midbrain cultures through 12-lipoxygenase. J Biol Chem 2003; 278: 21542-21549.
27. Li Y, Maher P, Schubert D. A role for 12-lipoxygenase in nerve cell death caused by glutathione depletion. Neuron 1997; 19: 453-463.
28. Chang WC, Nakao J, Orimo H, Murota S. Effects of reduced glutathione on the 12-lipoxygenase pathways in rat platelets. Biochem J 1982; 202: 771-776.
29. Maret W. Cellular zinc and redox states converge in the metallothionein/thionein pair. J Nutr 2003; 133: 1460S-1462S.
30. Wang H, Li J, Follett PL, Zhang Y, Cotanche DA, Jensen FE, et al. 12-Lipoxygenase plays a key role in cell death caused by glutathione depletion and arachidonic acid in rat oligodendrocytes. Eur J Neurosci 2004; 20: 2049-2058.
31. Muralikrishna Adibhatla R, Hatcher JF. Phospholipase A2, reactive oxygen species, and lipid peroxidation in cerebral ischemia. Free Radic Biol Med 2006; 40: 376-387.
32. Rossi R, Dalle-Donne I, Milzani A, Giustarini D. Oxidized forms of glutathione in peripheral blood as biomarkers of oxidative stress. Clin Chem 2006; 52: 1406-1414.
33. Mieyal JJ, Starke DW, Gravina SA, Dothey C, Chung JS. Thioltransferase in human red blood cells: purification and properties. Biochemistry 1991; 30: 6088-6097.
34. Pineda-Molina E, Klatt P, Vazquez J, Marina A, Garcia de Lacoba M, Perez-Sala D, et al. Glutathionylation of the p50 subunit of NF-kappaB: a mechanism for redox-induced inhibition of DNA binding. Biochemistry 2001; 40: 14134-14142.
35. Mohr S, Hallak H, de Boitte A, Lapetina EG, Brune B. Nitric oxide-induced S-glutathionylation and inactivation of glyceraldehyde-3-phosphate dehydrogenase. J Biol Chem 1999; 274: 9427-9430.
36. Ward NE, Stewart JR, Ioannides CG, O'Brian CA. Oxidant-induced S-glutathiolation inactivates protein kinase C-alpha (PKC-alpha): a potential mechanism of PKC isozyme regulation. Biochemistry 2000; 39: 10319-10329.
37. Wang J, Boja ES, Tan W, Tekle E, Fales HM, English S, et al. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 2001; 276: 47763-47766.
38. Dafre AL, Sies H, Akerboom T. Protein S-thiolation and regulation of microsomal glutathione transferase activity by the glutathione redox couple. Arch Biochem Biophys 1996; 332: 288-294.
39. Davis DA, Newcomb FM, Starke DW, Ott DE, Mieyal JJ, Yarchoan R. Thioltransferase (glutaredoxin) is detected within HIV-1 and can regulate the activity of glutathionylated HIV-1 protease in vitro. J Biol Chem 1997; 272: 25935-25940.
40. Okamoto T, Akaike T, Sawa T, Miyamoto Y, van der Vliet A, Maeda H. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J Biol Chem 2001; 276: 29596-29602.
41. Hurd TR, Costa NJ, Dahm CC, Beer SM, Brown SE, Filipovska A, et al. Glutathionylation of mitochondrial proteins. Antioxid Redox Signal 2005; 7: 999-1010.
42. Huang Z, Pinto JT, Deng H, Richie JP, Jr. Inhibition of caspase-3 activity and activation by protein glutathionylation. Biochem Pharmacol 2008; 75: 2234-2244.
43. Chang SM, Prados MD, Yung WK, Fine H, Junck L, Greenberg H, et al. Phase II study of neoadjuvant 1, 3-bis (2-chloroethyl)-1-nitrosourea and temozolomide for newly diagnosed anaplastic glioma: a North American Brain Tumor Consortium Trial. Cancer 2004; 100: 1712-1716.
44. Doroshenko N, Doroshenko P. Ion dependence of cytotoxicity of carmustine against PC12 cells. Eur J Pharmacol 2003; 476: 185-191.
45. Smith AC, Boyd MR. Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity. J Pharmacol Exp Ther 1984; 229: 658-663.
46. Navarro J, Obrador E, Pellicer JA, Aseni M, Vina J, Estrela JM. Blood glutathione as an index of radiation-induced oxidative stress in mice and humans. Free Radic Biol Med 1997; 22: 1203-1209.
47. Mkoji GM, Smith JM, Prichard RK. Glutathione redox state, lipid peroxide levels, and activities of glutathione enzymes in oltipraz-treated adult Schistosoma mansoni. Biochem Pharmacol 1989; 38: 4307-4313.
48. Leung SW, Mitchell JB, al-Nabulsi I, Friedman N, Newsome J, Belldegrun A, et al. Effect of L-buthionine sulfoximine on the radiation response of human renal carcinoma cell lines. Cancer 1993; 71: 2276-2285.
49. Mistry P, Harrap KR. Historical aspects of glutathione and cancer chemotherapy. Pharmacol Ther 1991; 49: 125-132.
50. Castillo M. Neuroradiology companion: methods, guidelines and imaging fundamentals, vol. 3rd edition. Lippincott Williams & Wilkins: Philadelphia, 2006.
51. Cherubini A, Ruggiero C, Polidori MC, Mecocci P. Potential markers of oxidative stress in stroke. Free Radic Biol Med 2005; 39: 841-852.
52. Hiramatsu M, Mori A. Reduced and oxidized glutathione in brain and convulsions. Neurochem Res 1981; 6: 301-306.
53. Adams JD, Jr., Klaidman LK, Odunze IN, Shen HC, Miller CA. Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. Mol Chem Neuropathol 1991; 14: 213-226.
54. Maher P. The effects of stress and aging on glutathione metabolism. Ageing Res Rev 2005; 4: 288-314.
2- Toxicol In Vitro. 2014 Aug;28(5):1006-15. doi: 10.1016/j.tiv.2014.04.017. Epub 2014 May 6.
GSSG/GSH ratios in cryopreserved rat and human hepatocytes as a biomarker for drug induced oxidative stress. (see attached file).
The formation of reactive oxygen species (ROS) could cause cellular damage and eventually lead to apoptosis and necrosis. The ratio between oxidized glutathione and reduced glutathione (GSSG-to-GSH ratio) has been used as an important in vitro and in vivo biomarker of the redox balance in the cell and consequently of cellular oxidative stress. This paper optimizes a LC-MS/MS method for the simultaneous determination of GSH and GSSG. The proposed method is based on the derivatization of reduced GSH using iodoacetic acid (IAA) in order to prevent its rapid oxidation to GSSG during sample preparation. The optimized analytical method was applied to evaluate the effect of different pharmaceutical agents on GSSG-to-GSH ratio in cryopreserved rat and human hepatocytes in culture. Hepatocyte viabilities were also determined at the same time by using the WST-1 assay as a direct measurement of cell mitochondrial respiration. The results obtained demonstrate that cryopreserved rat and human hepatocytes in culture are reliable in vitro models for the evaluation of cellular oxidative stress. In addition, the GSSG-to-GSH ratio measurements could be a biomarker of hepatotoxicity providing similar results to those of cytotoxicity assay.
http://www.ncbi.nlm.nih.gov/pubmed/24809893
3-Scand J Med Sci Sports 2009 & 2009 John Wiley & Sons A/S
doi: 10.1111/j.1600-0838.2009.00987.x
Plasma antioxidant responses and oxidative stress following a soccer
game in elite female players
H. Andersson1 , A. Karlsen2 , R. Blomhoff2 , T. Raastad3 , F. Kadi1 1
School of Health and Medical Sciences, O¨rebro University, O¨rebro, Sweden, 2
Department of Nutrition, Institute of Basic Medical
Sciences, University of Oslo, Oslo, Norway, 3
Norwegian School of Sport Sciences, Oslo, Norway
Corresponding author: Fawzi Kadi, School of Health and Medical Sciences, O¨rebro University, 701 82 O¨rebro, Sweden. Tel:
We aimed to investigate markers of oxidative stress and levels of endogenous and dietary antioxidants in 16 elite female soccer players in response to a 90-min game (average intensity 82 3% HRpeak). Blood samples were taken before, immediately and 21 h after the game. Plasmaoxidized glutathione, the ratio of reduced to oxidized glutathione (GSH:GSSG) and lipid peroxidation measured by d-ROMs were used as markers of oxidative stress. Plasma endogenous [uric acid, total glutathione (TGSH)] and dietary antioxidants (a-tocopherol, ascorbic acid, total
carotenoids and polyphenols) were analyzed using liquid chromatography and the Folin–Ciocalteu method. Exercise induced an acute increase (Po0.05) in GSSG, uric acid, TGSH, a-tocopherol, and ascorbic acid. In parallel, the GSH:GSSG ratio and polyphenols decreased (Po0.05). GSSG, GSH:GSSG ratio, uric acid, TGSH, and ascorbic acid returned to baseline at 21 h, while polyphenols and a-tocopherol remained altered. Total carotenoids increased above baseline only at 21 h (Po0.05). Lipid peroxidation, measured by d-ROMs, remained unchanged throughout the study. Thus, intermittent exercise in well-trained female
athletes induces a transient increase in GSSG and a decrease in the GSH:GSSG ratio, which is effectively balanced by the recruitment of both endogenous and dietary antioxidants, resulting in the absence of lipid peroxidation measured by d-ROMs.
The objectives of this study were to determine whether differences in the size and composition of coarse (2.5-10 micro m), fine (< 2.5 microm), and ultrafine (< 0.1 microm) particulate matter (PM) are related to their uptake in macrophages and epithelial cells and their ability to induce oxidative stress. The premise for this study is the increasing awareness that various PM components induce pulmonary inflammation through the generation of oxidative stress. Coarse, fine, and ultrafine particles (UFPs) were collected by ambient particle concentrators in the Los Angeles basin in California and used to study their chemical composition in parallel with assays for generation of reactive oxygen species (ROS) and ability to induce oxidative stress in macrophages and epithelial cells. UFPs were most potent toward inducing cellular heme oxygenase-1 (HO-1) expression and depleting intracellular glutathione. HO-1 expression, a sensitive marker for oxidative stress, is directly correlated with the high organic carbon and polycyclic aromatic hydrocarbon (PAH) content of UFPs. The dithiothreitol (DTT) assay, a quantitative measure of in vitro ROS formation, was correlated with PAH content and HO-1 expression. UFPs also had the highest ROS activity in the DTT assay. Because the small size of UFPs allows better tissue penetration, we used electron microscopy to study subcellular localization. UFPs and, to a lesser extent, fine particles, localize in mitochondria, where they induce major structural damage. This may contribute to oxidative stress. Our studies demonstrate that the increased biological potency of UFPs is related to the content of redox cycling organic chemicals and their ability to damage mitochondria.
Bonvallot V, Baeza-Squiban A, Baulig A, Brulant S, Boland S, Muzeau F, Barouki R, Marano F. Organic compounds from diesel exhaust particles elicit a proinflammatory response in human airway epithelial cells and induce cytochrome p450 1A1 expression. Am J Respir Cell Mol Biol. 2001 Oct;25(4):515–521. [PubMed]
Choi AM, Alam J. Heme oxygenase-1: function, regulation, and implication of a novel stress-inducible protein in oxidant-induced lung injury. Am J Respir Cell Mol Biol. 1996 Jul;15(1):9–19. [PubMed]
Frampton MW. Systemic and cardiovascular effects of airway injury and inflammation: ultrafine particle exposure in humans. Environ Health Perspect. 2001 Aug;109 (Suppl 4):529–532. [PMC free article] [PubMed]
Hiura TS, Kaszubowski MP, Li N, Nel AE. Chemicals in diesel exhaust particles generate reactive oxygen radicals and induce apoptosis in macrophages. J Immunol. 1999 Nov 15;163(10):5582–5591. [PubMed]
Hiura TS, Li N, Kaplan R, Horwitz M, Seagrave JC, Nel AE. The role of a mitochondrial pathway in the induction of apoptosis by chemicals extracted from diesel exhaust particles. J Immunol. 2000 Sep 1;165(5):2703–2711. [PubMed]
Horváth I, Donnelly LE, Kiss A, Paredi P, Kharitonov SA, Barnes PJ. Raised levels of exhaled carbon monoxide are associated with an increased expression of heme oxygenase-1 in airway macrophages in asthma: a new marker of oxidative stress. Thorax. 1998 Aug;53(8):668–672. [PMC free article] [PubMed]
Kawasaki S, Takizawa H, Takami K, Desaki M, Okazaki H, Kasama T, Kobayashi K, Yamamoto K, Nakahara K, Tanaka M, et al. Benzene-extracted components are important for the major activity of diesel exhaust particles: effect on interleukin-8 gene expression in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2001 Apr;24(4):419–426. [PubMed]
Kumagai Y, Arimoto T, Shinyashiki M, Shimojo N, Nakai Y, Yoshikawa T, Sagai M. Generation of reactive oxygen species during interaction of diesel exhaust particle components with NADPH-cytochrome P450 reductase and involvement of the bioactivation in the DNA damage. Free Radic Biol Med. 1997;22(3):479–487. [PubMed]
Kumagai Yoshito, Koide Sachie, Taguchi Keiko, Endo Akiko, Nakai Yumi, Yoshikawa Toshikazu, Shimojo Nobuhiro. Oxidation of proximal protein sulfhydryls by phenanthraquinone, a component of diesel exhaust particles. Chem Res Toxicol. 2002 Apr;15(4):483–489. [PubMed]
Li Ning, Kim Seongheon, Wang Meiying, Froines John, Sioutas Constantinos, Nel Andre. Use of a stratified oxidative stress model to study the biological effects of ambient concentrated and diesel exhaust particulate matter. Inhal Toxicol. 2002 May;14(5):459–486. [PubMed]
Li N, Venkatesan MI, Miguel A, Kaplan R, Gujuluva C, Alam J, Nel A. Induction of heme oxygenase-1 expression in macrophages by diesel exhaust particle chemicals and quinones via the antioxidant-responsive element. J Immunol. 2000 Sep 15;165(6):3393–3401. [PubMed]
Li Ning, Wang Meiying, Oberley Terry D, Sempf Joan M, Nel Andre E. Comparison of the pro-oxidative and proinflammatory effects of organic diesel exhaust particle chemicals in bronchial epithelial cells and macrophages. J Immunol. 2002 Oct 15;169(8):4531–4541. [PubMed]
Maines MD. The heme oxygenase system: a regulator of second messenger gases. Annu Rev Pharmacol Toxicol. 1997;37:517–554. [PubMed]
Miyabara Y, Ichinose T, Takano H, Lim HB, Sagai M. Effects of diesel exhaust on allergic airway inflammation in mice. J Allergy Clin Immunol. 1998 Nov;102(5):805–812. [PubMed]
Monks TJ, Hanzlik RP, Cohen GM, Ross D, Graham DG. Quinone chemistry and toxicity. Toxicol Appl Pharmacol. 1992 Jan;112(1):2–16. [PubMed]
Nel AE, Diaz-Sanchez D, Li N. The role of particulate pollutants in pulmonary inflammation and asthma: evidence for the involvement of organic chemicals and oxidative stress. Curr Opin Pulm Med. 2001 Jan;7(1):20–26. [PubMed]
Nel AE, Diaz-Sanchez D, Ng D, Hiura T, Saxon A. Enhancement of allergic inflammation by the interaction between diesel exhaust particles and the immune system. J Allergy Clin Immunol. 1998 Oct;102(4 Pt 1):539–554. [PubMed]
Nemmar A, Hoet PHM, Vanquickenborne B, Dinsdale D, Thomeer M, Hoylaerts MF, Vanbilloen H, Mortelmans L, Nemery B. Passage of inhaled particles into the blood circulation in humans. Circulation. 2002 Jan 29;105(4):411–414. [PubMed]
Nightingale JA, Maggs R, Cullinan P, Donnelly LE, Rogers DF, Kinnersley R, Chung KF, Barnes PJ, Ashmore M, Newman-Taylor A. Airway inflammation after controlled exposure to diesel exhaust particulates. Am J Respir Crit Care Med. 2000 Jul;162(1):161–166. [PubMed]
Oberdorster G. Significance of particle parameters in the evaluation of exposure-dose-response relationships of inhaled particles. Inhal Toxicol. 1996;8 (Suppl):73–89. [PubMed]
Oberdörster Günter, Utell Mark J. Ultrafine particles in the urban air: to the respiratory tract--and beyond? Environ Health Perspect. 2002 Aug;110(8):A440–A441. [PMC free article] [PubMed]
Penning TM, Burczynski ME, Hung CF, McCoull KD, Palackal NT, Tsuruda LS. Dihydrodiol dehydrogenases and polycyclic aromatic hydrocarbon activation: generation of reactive and redox active o-quinones. Chem Res Toxicol. 1999 Jan;12(1):1–18. [PubMed]
Penttinen P, Timonen KL, Tiittanen P, Mirme A, Ruuskanen J, Pekkanen J. Number concentration and size of particles in urban air: effects on spirometric lung function in adult asthmatic subjects. Environ Health Perspect. 2001 Apr;109(4):319–323. [PMC free article] [PubMed]
Saldiva Paulo H N, Clarke Robert W, Coull Brent A, Stearns Rebecca C, Lawrence Joy, Murthy G G Krishna, Diaz Edgar, Koutrakis Petros, Suh Helen, Tsuda Akira, et al. Lung inflammation induced by concentrated ambient air particles is related to particle composition. Am J Respir Crit Care Med. 2002 Jun 15;165(12):1610–1617. [PubMed]
Samet JM, Dominici F, Curriero FC, Coursac I, Zeger SL. Fine particulate air pollution and mortality in 20 U.S. cities, 1987-1994. N Engl J Med. 2000 Dec 14;343(24):1742–1749. [PubMed]
Takano Hirohisa, Yanagisawa Rie, Ichinose Takamichi, Sadakane Kaori, Inoue Ken-ichiro, Yoshida Sei-ichi, Takeda Ken, Yoshino Shin, Yoshikawa Toshikazu, Morita Masatoshi. Lung expression of cytochrome P450 1A1 as a possible biomarker of exposure to diesel exhaust particles. Arch Toxicol. 2002 Apr;76(3):146–151. [PubMed]
Tietze F. Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Anal Biochem. 1969 Mar;27(3):502–522. [PubMed]
Tsien A, Diaz-Sanchez D, Ma J, Saxon A. The organic component of diesel exhaust particles and phenanthrene, a major polyaromatic hydrocarbon constituent, enhances IgE production by IgE-secreting EBV-transformed human B cells in vitro. Toxicol Appl Pharmacol. 1997 Feb;142(2):256–263. [PubMed]
Utell MJ, Frampton MW. Acute health effects of ambient air pollution: the ultrafine particle hypothesis. J Aerosol Med. 2000 Winter;13(4):355–359. [PubMed]
Wichmann HE, Spix C, Tuch T, Wölke G, Peters A, Heinrich J, Kreyling WG, Heyder J. Daily mortality and fine and ultrafine particles in Erfurt, Germany part I: role of particle number and particle mass. Res Rep Health Eff Inst. 2000 Nov;(98):5–94. [PubMed]
Yang AH, Gould-Kostka J, Oberley TD. In vitro growth and differentiation of human kidney tubular cells on a basement membrane substrate. In Vitro Cell Dev Biol. 1987 Jan;23(1):34–46. [PubMed]
Although I do not want to discourage colleagues from writing extensive comments on research gate questions, I have to make some critical comments on the answer you received from Rafik Karaman. In particular, the first article added to his mail contains some misleading or wrong statements.
1. As is evident from the title of ref.1, Alton Meister introduced the gamma-Glu cycle as an amino acid transport system. This hypothesis turned out to be wrong, and I hate to see my old friend Alton Meister always quoted for one of the very few mistakes he made.
2. It is not “widely acknowledged that changes in the cellular reduced/oxidized glutathione ratio trigger signal transduction mechanisms influencing cell survival.” Ratios do not regulate anything. Glutathione-dependent redox regulation is achieved by bimolecular reactions of reduced glutathione with target proteins, less likely of GSSG with target proteins. In fact, the only proteins with reasonable affinity to GSSG I am aware of are glutathione reductase glutaredoxins and GSSG transporters.
3. The sentence:” GSSG is capable of causing protein S-glutathionylation or reversible formation of protein mixed disulfides (protein-SSG)” is correct in principle. However, it describes the least likely mechanism of mixed disulfide formation, because the GSSG levels are usually too low. There is increasing evidence that the preferred route is sulfenic acid formation in susceptible proteins followed by reaction with GSH.
4. It has been known for almost half a century that lipoxygenases in general are inhibited by GSH plus any kind of GSH peroxidase. The generally accepted interpretation of this phenomenon is that their catalytic iron has to be oxidized for activity, which is prevented by depletion of either GSH or glutathione peroxidase. There is no need to involve GSSG as an inhibitor of lipoxygenases and I am not aware of any experimental evidence supporting this concept.
5. In vitro experiments with exogenous GSSG are not likely very relevant. The extracellular concentrations of GSSG are in the micromolar range, it is degrade with a half life time around one minute and am not aware of any experiment demonstrating (patho)physiological consequences of GSSG variation within the physiological range.
There are some reasonable reviews on these topics available (written by me and by others), e. g. Brigelius-Flohé & Flohé, ARS 2011; Forman, FRBM 2997; Janssen-Heininger et al, FRBM 2008; Forman et al, Biochemistry 2010, Flohé, Free Rad Res 2016). Enjoy reading!